September 26, 2013
…organization committed to stopping Alzheimer’s by 2020. Proceeds from the performance benefit the UC San Diego Shiley-Marcos Alzheimer’s Disease Research Center and WomenAgainst Alzheimer’s – the first national network of women in leadership positions working to speed the pace of research and build momentum to end Alzheimer’s disease. “Through my…
August 21, 2023
New results from researchers at UC San Diego School of Medicine suggest that intermittent fasting could be an effective treatment approach for Alzheimer’s disease. Mice fed on a time-restricted schedule had better memory and less accumulation of amyloid proteins in the brain compared to controls.
August 9, 2023
Promising preclinical results from UC San Diego show hematopoietic stem cell therapy was effective in rescuing memory loss, neuroinflammation and beta amyloid build-up in a mouse model of Alzheimer’s disease.
July 3, 2019
On July 1, 2019, USC and UC San Diego reached a settlement in the ongoing Alzheimer’s disease research lawsuit, Regents of the University of California v. Aisen et al.
November 28, 2022
UC San Diego researchers identify the PKCα enzyme as a promising therapeutic target in Alzheimer’s disease; a mutation that increases its activity led to biochemical, cellular and cognitive impairments in mice.
November 21, 2023
UC San Diego’s Center for Scientific Computation in Imaging has received a $7.5 million grant from the National Institutes of Health to continue its interdisciplinary exploration of diffusion magnetic resonance imaging (dMRI) work related to Alzheimer’s disease.
April 23, 2024
Using state-of-the-art microscopy techniques developed on campus, researchers at UC San Diego School of Medicine have shed new light on the underlying mechanisms driving Alzheimer’s disease.
January 13, 2016
…of California, San Diego School of Medicine and the Alzheimer’s Disease Cooperative Study (ADCS), in collaboration with AC Immune, a biotechnology company based in Switzerland, will test the safety and tolerability of an immunotherapy vaccine that targets Alzheimer’s disease-like characteristics in adults with Down syndrome.
May 15, 2012
Researchers at the Comprehensive Alzheimer’s Program at the University of California, San Diego School of Medicine have announced two new clinical trials for patients with either mild to moderate Alzheimer’s disease (AD) and one trial for Mild Cognitive Impairment.
November 13, 2020
UC San Diego researchers have identified new mechanisms in neurons that cause Alzheimer’s disease. In particular, they discovered that structural changes in chromatin trigger neurons to lose their specialized function and revert to a precursor-like state.
